Published in J Immunol on April 01, 1969
Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol (1985) 2.54
Solid phase radioimmunoassay for typing herpes simplex viral antibodies in human sera. J Clin Microbiol (1975) 1.63
Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera. Infect Immun (1981) 1.41
Determination of herpes simplex virus type-specific antibodies by enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.21
Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B. J Virol (1991) 1.01
Identification, transfer, and characterization of cloned herpes simplex virus invasiveness regions. J Virol (1989) 0.85
Concentrations of idoxuridine in serum, urine, and cerebrospinal fluid of patients with suspected diagnoses of Herpesvirus hominis encephalitis. J Clin Invest (1972) 0.82
Comparison of indirect hemagglutination and indirect immunofluorescence tests with microneutralization tests for detection of type-specific Herpesvirus hominis antibody. J Clin Microbiol (1979) 0.81
Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med (1977) 25.00
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med (1997) 7.59
Ampicillin-resistant Haemophilus influenzae type B infection. JAMA (1974) 5.90
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 5.12
Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol (1967) 5.07
Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03
A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37
Infection with herpes-simplex viruses 1 and 2. 3. N Engl J Med (1973) 3.89
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature (1998) 3.69
A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66
The natural history of herpes simplex virus infection of mother and newborn. Pediatrics (1980) 3.65
Comparative study of diagnostic procedures for congenital cytomegalovirus infection. Pediatrics (1980) 3.53
Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31
Are amyotrophic lateral sclerosis patients cognitively normal? Neurology (2003) 3.21
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The epidemiology of AIDS. Public Health Rep (1983) 3.00
A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med (1989) 2.94
Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. Intervirology (1981) 2.92
Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90
Longitudinal volumetric MRI change and rate of cognitive decline. Neurology (2005) 2.90
Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med (1973) 2.87
Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections. Am J Epidemiol (1970) 2.83
Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics (1980) 2.70
Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis (1982) 2.70
Typing of Herpesvirus hominis strains by a direct immunofluorescent technique. Proc Soc Exp Biol Med (1969) 2.64
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Infection of the newborn with herpesvirus hominis. Adv Pediatr (1970) 2.61
Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55
Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol (1985) 2.54
Cytology and histopathology of cervical herpes simplex infection. Cancer (1966) 2.52
Different patterns of neurologic involvement with herpes simplex virus types 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J Infect Dis (1973) 2.52
Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol (1976) 2.49
Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol (1971) 2.40
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology (2002) 2.35
Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis. Proc Soc Exp Biol Med (1968) 2.34
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25
Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24
The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22
Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells. J Immunol (1977) 2.21
Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. Am J Epidemiol (1970) 2.15
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology (2003) 2.14
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
A community surveillance system of infectious diseases in the greater Atlanta area. Am J Public Health Nations Health (1966) 2.11
Inhibitory effect of heparin on herpes simplex virus. J Bacteriol (1964) 2.11
Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer (1969) 2.10
Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology (2005) 2.10
Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen (2008) 2.00
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Genital herpes simplex infection. Virologic and cytologic studies. Obstet Gynecol (1967) 1.95
A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology (2005) 1.93
Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis (1977) 1.88
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology (2000) 1.82
Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA. J Infect Dis (1979) 1.82
Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol (1974) 1.79
Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol (1994) 1.79
Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology (2006) 1.78
Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology (1997) 1.77
Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology (2000) 1.76
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin Exp Immunol (1977) 1.73
Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol (1988) 1.71
A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis (1990) 1.70
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies. Z Immunitatsforsch Exp Klin Immunol (1971) 1.67
Protein composition of coronavirus OC 43. Virology (1972) 1.66
Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology (2004) 1.64
Type-specific surface antigens of cells infected with herpes simplex virus (1 and 2). Proc Soc Exp Biol Med (1971) 1.64
Infection with herpes-simplex viruses 1 and 2. II. N Engl J Med (1973) 1.64
Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med (1996) 1.63
Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Am J Epidemiol (1970) 1.60
WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ (1970) 1.58
Age-related heterologous antibody responses to influenza virus vaccination. J Infect Dis (1977) 1.57
Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J (1973) 1.56
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. N Engl J Med (1999) 1.55
Coronaviridae. Intervirology (1975) 1.55
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ (1969) 1.55
Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res (1996) 1.53
The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann N Y Acad Sci (1980) 1.52
The epidemiology of Type 2 (genital) herpes simplex virus infection. Obstet Gynecol Surv (1972) 1.52
Swine influenza virus infections in humans. J Infect Dis (1977) 1.50
Filamentous structures of type 2 Herpesvirus hominis infection of the chorioallantoic membrane. J Virol (1969) 1.50